Keyphrases
Diabetes
100%
Racial Disparities
100%
Diabetes Medications
100%
Socioeconomic Disparities
100%
Race-ethnicity
50%
Native American
25%
Socioeconomic Factors
25%
GLP-1 Receptor Agonist
25%
Alaskan Native
25%
Demographic Characteristics
12%
Low-income
12%
Cardiovascular Disease
12%
Health Outcomes
12%
High Cost
12%
Hypoglycemia
12%
Type 2 Diabetic Patients
12%
Hispanic Americans
12%
High Burden
12%
Cox Proportional Hazards Model
12%
Clinical Characteristics
12%
Black Hispanic
12%
Chronic Kidney Disease
12%
Racial-ethnic Groups
12%
Other-race
12%
Family Income
12%
Dipeptidyl peptidase-4 (DPP-4)
12%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
12%
Time to Initiation
12%
Medication Classes
12%
High Income Group
12%
Medication Initiation
12%
Psychology
Chronic Disorder
100%
Proportional Hazards Regression Model
100%
Family Income
100%
Kidney Disease
100%
Pharmacology, Toxicology and Pharmaceutical Science
Glucagon Like Peptide 1 Receptor Agonist
100%
Cardiovascular Disease
50%
Non Insulin Dependent Diabetes Mellitus
50%
Hypoglycemia
50%
Chronic Kidney Failure
50%
Dipeptidyl Peptidase IV Inhibitor
50%
Medicine and Dentistry
Diabetes
100%
Drug Therapy
100%
American Indian
20%
Glucagon-Like Peptide-1 Agonist
20%
Cardiovascular Disease
10%
Health Outcomes
10%
Ethnic Disparity
10%
Health Care Cost
10%
Hypoglycemia
10%
Patient with Type 2 Diabetes
10%
Ethnic Group
10%
Chronic Kidney Disease
10%
Proportional Hazards Model
10%
Dipeptidyl Peptidase-4 Inhibitor
10%
Neuroscience
Glucagon-Like Peptide-1 Agonist
100%
Hypoglycemia
50%
Dipeptidyl Peptidase-4 Inhibitor
50%